After 13 years, Neuro-Bio has recently relocated from Culham Campus, Abingdon to Central Oxford. Culham Campus has been the setting for many important milestones in Neuro-Bio’s journey, and we are immensely grateful to everyone at the Campus who has supported us along...
Neuro-Bio was featured in a SelectScience webinar, “How Synthetic Binders Are Transforming Diagnostics and Molecular Biology.” The webinar explored how synthetic binders are providing effective alternatives where traditional antibodies can fall short. Baroness Susan...
We are pleased to announce the publication of our latest paper, “Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer’s Disease: A Methodological Approach.” The paper outlines a methodological framework for assessing...
On October 31, 2024, Baroness Susan Greenfield delivered a thought-provoking speech in the House of Lords on the critical impact of science and technology on the UK economy. She emphasized the need for enhanced investment in biotech, especially for tackling...
Welcome to this video featuring Baroness Greenfield, who delves into the remarkable progress in Alzheimer’s research over the past fifty years. In this enlightening talk, she explores the increasing personal impact of the disease, highlighting the disturbing...
